Luanne Hall-Stoodley

Ligocyte Pharmaceuticals, Inc.

$965,558

Attributed

$2,788,050

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $729.6K · FY2022–25

$1M$750K$500K$250K$0

'22

'23

'24

'25

Funding mix

By agency

NIH$2,788,050 · 4

By mechanism

R01$2,139,844 · 1

R21$427,219 · 1

R41$212,987 · 1

R13$8,000 · 1

Top collaborators

Others in their field

Top investigators on “Cystic Fibrosis”

John F Engelhardt · University Of Iowa$42,933,706
Michael R Knowles · University Of North Carolina Chapel Hill$30,250,682
David A Stoltz · University Of Iowa$25,455,359
Joseph Zabner · University Of Iowa$25,382,103
Paul B McCray · University Of Iowa$25,146,293
Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955

Research focus

Cystic FibrosisNon-Tuberculosis MycobacteriaInfectionPersonsCommunitiesPathogenCystic Fibrosis PatientsPseudomonas AeruginosaMycobacterium AbscessusMediatingChronic InfectionLung DiseasesLung InfectionsVariantAntibiotic TherapyInflammatoryAntibioticsAntimicrobialInsightAffectNutritionCystic Fibrosis InfectionChronicCell Physiology

Grant awards (8)

Resue of CF phagocyte function with CFTR modulator therapy$503,459

R01 · FY2025 · HL

Surface dependent inhibition of Mycobacterium abscessus by Pseudomonas aeruginosa$190,969

R21 · FY2025 · AI

Resue of CF phagocyte function with CFTR modulator therapy$493,389

R01 · FY2024 · HL

Surface dependent inhibition of Mycobacterium abscessus by Pseudomonas aeruginosa$236,250

R21 · FY2024 · AI

Resue of CF phagocyte function with CFTR modulator therapy$531,709

R01 · FY2023 · HL

Rescue of CF phagocyte function with CFTR modulator therapy$611,287

R01 · FY2022 · HL

Many Hosts of Mycobacteria 9 Conference$8,000

R13 · FY2022 · AI

Tubercle Bacilli Binding to Host Cells: Vaccine Design$212,987

R41 · FY2002 · AI